Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial.

Bots ML, Ford I, Lloyd SM, Laurent S, Touboul PJ, Hennerici MG; Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin With Terutroban in Patients With a History of Ischemic Stroke or Transient Ischemic Attack Vascular Ultrasound Study Investigators.

Stroke. 2014 Aug;45(8):2348-53. doi: 10.1161/STROKEAHA.114.004775. Epub 2014 Jun 24.

PMID:
25070960
[PubMed - in process]
2.

Psychological Changes in Melanoma Patients During Ipilimumab Treatment Compared to Low-Dose Interferon Alpha Therapy-A Follow-Up Study of First Experiences.

Kovács P, Pánczél G, Borbola K, Juhász G, Liszkay G.

Pathol Oncol Res. 2014 Apr 27. [Epub ahead of print]

PMID:
24771289
[PubMed - as supplied by publisher]
3.

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.

Giovannoni G, Gold R, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, McNeill M, Amaravadi L, Sweetser M, Elkins J, O'Neill G; SELECTION Study Investigators.

Lancet Neurol. 2014 May;13(5):472-81. doi: 10.1016/S1474-4422(14)70039-0. Epub 2014 Mar 19.

PMID:
24656609
[PubMed - indexed for MEDLINE]
4.

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

Gold R, Giovannoni G, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, Robinson R, Riester K, Rana J, Elkins J, O'Neill G; SELECT study investigators.

Lancet. 2013 Jun 22;381(9884):2167-75. doi: 10.1016/S0140-6736(12)62190-4. Epub 2013 Apr 4.

PMID:
23562009
[PubMed - indexed for MEDLINE]
5.

Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.

Lees KR, Bornstein N, Diener HC, Gorelick PB, Rosenberg G, Shuaib A; MACSI Investigators.

Stroke. 2013 Mar;44(3):580-4. doi: 10.1161/STROKEAHA.111.000013. Epub 2013 Feb 7. Erratum in: Stroke. 2013 Mar;44(3) :e23.

PMID:
23391764
[PubMed - indexed for MEDLINE]
Free Article
6.

Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.

Bihari I, Pánczél G, Kovacs J, Beygo J, Fragapane E.

Clin Vaccine Immunol. 2012 Dec;19(12):1943-8. doi: 10.1128/CVI.00373-12. Epub 2012 Oct 17.

PMID:
23081815
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[The importance of fine needle aspiration cytology in the management of recurrent and metastatic melanoma].

Pánczél G, Liszkay G, Borbola K, Balatoni T, Hunyadi J.

Orv Hetil. 2012 Sep 9;153(36):1419-23. doi: 10.1556/OH.2012.29434. Hungarian.

PMID:
22951409
[PubMed - indexed for MEDLINE]
8.

Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function.

Meltzer EO, Kuna P, Nolte H, Nayak AS, Laforce C; P04073 Study Investigators.

Eur Respir J. 2012 Feb;39(2):279-89. doi: 10.1183/09031936.00020310. Epub 2011 Aug 4.

PMID:
21828036
[PubMed - indexed for MEDLINE]
Free Article
9.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.

Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Erratum in: Lancet. 2011 Jul 30;378(9789):402.

PMID:
21616527
[PubMed - indexed for MEDLINE]
10.

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.

Khatri B, Barkhof F, Comi G, Hartung HP, Kappos L, Montalban X, Pelletier J, Stites T, Wu S, Holdbrook F, Zhang-Auberson L, Francis G, Cohen JA; TRANSFORMS Study Group.

Lancet Neurol. 2011 Jun;10(6):520-9. doi: 10.1016/S1474-4422(11)70099-0. Epub 2011 May 13.

PMID:
21571593
[PubMed - indexed for MEDLINE]
11.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators.

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

PMID:
21428765
[PubMed - indexed for MEDLINE]
Free Article
12.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
[PubMed - indexed for MEDLINE]
13.

Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.

Weinstein SF, Corren J, Murphy K, Nolte H, White M; Study Investigators of P04431.

Allergy Asthma Proc. 2010 Jul-Aug;31(4):280-9. doi: 10.2500/aap.2010.31.3381. Epub 2010 Aug 3.

PMID:
20687982
[PubMed - indexed for MEDLINE]
14.

Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.

Nathan RA, Nolte H, Pearlman DS; P04334 Study Investigators.

Allergy Asthma Proc. 2010 Jul-Aug;31(4):269-79. doi: 10.2500/aap.2010.31.3364. Epub 2010 Jul 30.

PMID:
20678306
[PubMed - indexed for MEDLINE]
15.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group.

N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20.

PMID:
20089954
[PubMed - indexed for MEDLINE]
Free Article
16.

[Posterior ischaemic optic neuropathy].

Boór K, Kovács K, Rózsa A, Pánczél G, Szilvássy I, Gács G.

Ideggyogy Sz. 2009 May 30;62(5-6):191-4. Hungarian.

PMID:
19579669
[PubMed - indexed for MEDLINE]
17.

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.

Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16.

PMID:
19372653
[PubMed - indexed for MEDLINE]
18.

Vascular disease risk factors and findings in patients with Alzheimer's disease.

Tariska P, Klein V, Pánczél G, Vitrai J, Knolmayer J, Mészáros A, Urbanics K, Kiss E.

Arch Gerontol Geriatr. 1997 Nov-Dec;25(3):237-43.

PMID:
18653111
[PubMed]
19.

Prevalence of stroke/cardiovascular risk factors in rural Hungary--a cross-sectional descriptive study.

Bodo M, Thuróczy G, Pánczél G, Sipos K, Iliás L, Szonyi P, Bodó M Jr, Nebella T, Bányász A, Nagy Z.

Ideggyogy Sz. 2008 Mar 30;61(3-4):87-96.

PMID:
18459449
[PubMed - indexed for MEDLINE]
20.

Visually evoked blood flow responses and vasoneuronal coupling in partial epilepsy.

Panczel G, Pohlmann-Eden B.

Acta Neurol Scand. 2004 Nov;110(5):308-12.

PMID:
15476459
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk